Key result
Pleural epithelioid hemangioendothelioma is a rare, aggressive malignancy with a mean survival of 9.6 months and no established standard treatment.
Case Report (n=28)
Pleural epithelioid hemangioendothelioma is a rare, aggressive malignancy that presents with non-specific symptoms like chest pain and requires early VATS for diagnosis and symptom management.
Raises awareness for prompt VATS in atypical pleural disease; leaves open effective therapies for this orphan malignancy.
Epithelioid hemangioendothelioma (EHE) is a rare malignant cancer of vascular origin that can affect multiple and varied tissue sites. A subtype of EHE, pulmonary epithelioid hemangioendothelioma (PHE), is more unusual with only 200 reported cases. Of these, only 27 have been classified as pleural in origin. Based on available literature, the average age of presentation of pleural PHE is 45.7 years with a male preponderance of 2.375. A summary of all published case reports reveals significant heterogeneity both in presentation and management. Here we add to this knowledge-base with a report of an unusual case of pleural PHE in a 36-year-old female who presented with a 6-week history of chest pain and breathlessness. Significant challenges in the diagnosis and management of patients with pleural PHE exist, including a wide initial differential diagnosis and difficulties in obtaining tissue specimens, coupled with relatively limited treatment options. Early referral to a cardiothoracic center for video-assisted thoracoscopic biopsy is crucial in facilitating a diagnosis and allowing adequate pleural drainage for symptomatic relief.
No takes yet. Share an insight, caveat, or question.
Salijevska et al. (2015) conducted a case report in Pleural Epithelioid Hemangioendothelioma (n=28). Various treatments including chemotherapy (e.g., carboplatin, etoposide, paclitaxel) and surgery was evaluated on Survival. Pleural epithelioid hemangioendothelioma is a rare, aggressive malignancy with a mean survival of 9.6 months and no established standard treatment.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: